Spotlight Series: Mixed Dyslipidemia

Back to series

This case-based series seeks to educate healthcare providers on lipid-lowering management strategies by reviewing techniques surrounding LDL-C lowering and the role of additional lipoprotein analysis in risk stratification and treatment, treatment of mixed dyslipidemia in metabolic syndrome and diabetes mellitus, and therapies to raise HDL-C.

Mixed Dyslipidemia Topics

Recognition and Treatment of HDL-C in Mixed Dyslipidemia
Beyond LDL-C: The Value of Measuring Other Atherogenic Lipoproteins & Markers of Atherogenic Risk
Evaluation and Management of Atherogenic Risk in Metabolic Syndrome

Spotlight Series Planning Committee

Spotlight Series Chair:
Tyler J. Gluckman, MD

Faculty:
Kim K. Birtcher, MS, PharmD
Roger S. Blumenthal, MD, FACC, FAHA
Laurie A. Kopin, MS, ANP
Neil J. Stone, MD, FAHA
Daniel J. Rader, MD, FAHA

Spotlight Series Speakers

We will fulfill your request with an AHA APPROVED and TRAINED SPEAKER located in your area. Once your speaking engagement is confirmed, you will receive the speaker's name and background information.

Supported by an educational grant from Solvay Pharmaceuticals and Abbott Pharmaceuticals